Announcements Trials
Browse Landscape

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 7Lymphoma 4Neutropenia 3Lymphoma, Large B-Cell, Diffuse 3Testicular Neoplasms 2Testicular Germ Cell Tumor 2Multiple Myeloma 2Central Nervous System Neoplasms 2Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1Seminoma 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Lymphoma, Non-Hodgkin 1Febrile Neutropenia 1Endodermal Sinus Tumor 1Chemotherapy-induced Neutropenia 1

Interventions

Meropenem 2pegfilgrastim 1Vancomycin 1TKN732 1Simvastatin 1Piperacillin, Tazobactam Drug Combination 1Magnetic Resonance Myelography 1Levofloxacin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Ceftazidime 1Anti-Bacterial Agents 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Febrile Neutropenia × pegfilgrastim × Clear all
NCT04662892 2020-12-23

POEM

Coherus Oncology, Inc.

Unknown
200 enrolled
Classical hematology

Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡